Brief: Evolus Q1 Adjusted Gross Margin 69.5%
07/05/2024 21:05
May 07 (Reuters) - Evolus Q1 gross margin 68.3%. * Q1 gross profit USD 40.503 million * Q1 net income USD -13.109 million * outlook FY sales growth 31% * outlook FY sales USD 255-265 million
Recent news on Evolus
See all newsEvolus Inc reports results for the quarter ended June 30 - Earnings Summary
Evolus Q2 revenue rises 21%, lifts 2026 outlook
Brief: Evolus Q2 Product Revenue USD 83.35 Million
Evolus Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe